We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current DYAI market cap is 43.2M. The company's latest EPS is USD -0.2296 and P/E is -6.18.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 397k | 687k | 335k | 385k | 1.96M |
| Operating Income | -1.71M | -1.15M | -2.12M | -2.04M | -197k |
| Net Income | -1.62M | -2.07M | -2.01M | -2.05M | -203k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.68M | 1.6M | 2.4M | 2.93M | 2.9M |
| Operating Income | -9.26M | -9.96M | -14.63M | -10.12M | -7.17M |
| Net Income | -8.3M | -9.33M | -13.07M | -9.74M | -6.8M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.26M | 8.22M | 12.68M | 10.63M | 10.81M |
| Total Liabilities | 1.6M | 2.34M | 8.17M | 7.46M | 7.39M |
| Total Equity | 7.65M | 5.88M | 4.52M | 3.17M | 3.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 37.45M | 30.07M | 21.3M | 13.71M | 8.22M |
| Total Liabilities | 1.59M | 1.63M | 2.91M | 2.63M | 2.34M |
| Total Equity | 35.86M | 28.45M | 18.39M | 11.09M | 5.88M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.8M | -6.73M | -1.11M | -3.08M | -3.28M |
| Investing | 7.42M | 7.45M | -655k | -3.13M | -3.14M |
| Financing | N/A | N/A | 5.82M | 5.82M | 5.82M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.78M | -6.58M | -11.28M | -8.08M | -6.73M |
| Investing | 7.71M | 22.12M | 5.22M | -2.37M | 7.45M |
| Financing | 550k | 256k | 1.23M | 543k | N/A |
| Market Cap | 43.2M |
| Price to Earnings Ratio | -6.18 |
| Price to Sales Ratio | 14.49 |
| Price to Cash Ratio | 6.45 |
| Price to Book Ratio | 7.15 |
| Dividend Yield | - |
| Shares Outstanding | 29.59M |
| Average Volume (1 week) | 19.05k |
| Average Volume (1 Month) | 35.94k |
| 52 Week Change | -9.88% |
| 52 Week High | 2.67 |
| 52 Week Low | 0.9257 |
| Spread (Intraday) | 0.15 (10.27%) |
| Company Name | Dyadic International Inc |
| Address |
3411 silverside road tatnall building wilmington, delaware 19810 |
| Website | https://www.dyadic.com |
| Industry | biogenetic (human) (H4) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
